0000950170-24-001364.txt : 20240103
0000950170-24-001364.hdr.sgml : 20240103
20240103194005
ACCESSION NUMBER: 0000950170-24-001364
CONFORMED SUBMISSION TYPE: 3
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20231203
FILED AS OF DATE: 20240103
DATE AS OF CHANGE: 20240103
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: HUFF CURTIS W
CENTRAL INDEX KEY: 0001250127
ORGANIZATION NAME:
FILING VALUES:
FORM TYPE: 3
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-41403
FILM NUMBER: 24509228
MAIL ADDRESS:
STREET 1: 4510 LAMESA HWY
CITY: SNYDER
STATE: TX
ZIP: 79549
FORMER NAME:
FORMER CONFORMED NAME: HUFT CURTIS W
DATE OF NAME CHANGE: 20030628
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Freebird Investments LLC
CENTRAL INDEX KEY: 0001971406
ORGANIZATION NAME:
STATE OF INCORPORATION: TX
FISCAL YEAR END: 1231
FILING VALUES:
FORM TYPE: 3
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-41403
FILM NUMBER: 24509229
BUSINESS ADDRESS:
STREET 1: 2800 POST OAK BLVD., SUITE 2000
CITY: HOUSTON
STATE: TX
ZIP: 77056
BUSINESS PHONE: 713-961-0118
MAIL ADDRESS:
STREET 1: 2800 POST OAK BLVD., SUITE 2000
CITY: HOUSTON
STATE: TX
ZIP: 77056
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Freebird Partners LP
CENTRAL INDEX KEY: 0001955231
ORGANIZATION NAME:
STATE OF INCORPORATION: TX
FISCAL YEAR END: 1231
FILING VALUES:
FORM TYPE: 3
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-41403
FILM NUMBER: 24509230
BUSINESS ADDRESS:
STREET 1: 2800 POST OAK BLVD.
STREET 2: SUITE 2000
CITY: HOUSTON
STATE: TX
ZIP: 77056
BUSINESS PHONE: 713-961-0118
MAIL ADDRESS:
STREET 1: 2800 POST OAK BLVD.
STREET 2: SUITE 2000
CITY: HOUSTON
STATE: TX
ZIP: 77056
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Comera Life Sciences Holdings, Inc.
CENTRAL INDEX KEY: 0001907685
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
ORGANIZATION NAME: 03 Life Sciences
IRS NUMBER: 874706968
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 12 GILL STREET
STREET 2: SUITE 4650
CITY: WOBURN
STATE: MA
ZIP: 01801
BUSINESS PHONE: (617)871-2101
MAIL ADDRESS:
STREET 1: 12 GILL STREET
STREET 2: SUITE 4650
CITY: WOBURN
STATE: MA
ZIP: 01801
3
1
ownership.xml
3
X0206
3
2023-12-03
0
0001907685
Comera Life Sciences Holdings, Inc.
CMRA
0001955231
Freebird Partners LP
2800 POST OAK BLVD, SUITE 2000
HOUSTON
TX
77056
false
false
true
false
0001971406
Freebird Investments LLC
2800 POST OAK BLVD, SUITE 2000
HOUSTON
TX
77056
false
false
true
false
0001250127
HUFF CURTIS W
2800 POST OAK BLVD, SUITE 2000
HOUSTON
TX
77056
false
false
true
false
Common Stock, par value $0.0001 per share
1254776
D
Common Stock Purchase Warrant
1.23
2023-01-04
2028-01-04
Common Stock, par value $0.0001 per share
743242
D
Common Stock Purchase Warrant
0.6135
2024-02-01
2028-07-31
Common Stock, par value $0.0001 per share
1198044
D
Common Stock Purchase Warrant
0.6135
2023-09-11
2028-09-11
Common Stock, par value $0.0001 per share
513447
D
This report is filed jointly by Freebird Partners LP, a Texas limited partnership ("Freebird Partners"), Freebird Investments LLC, a Texas limited liability company ("Freebird Investments"), and Curtis W. Huff (each a "Reporting Person" and collectively, the "Reporting Persons") in connection with their respective direct and indirect ownership of common stock, par value $0.0001 ("Common Stock") of Comera Life Sciences Holdings, Inc. (the "Company"). These securities of the Company are held of record by Freebird Partners. Freebird Investments serves as the general partner of Freebird Partners. Curtis W. Huff is the sole member of Freebird Investments. By virtue of these relationships, each of Freebird Investments and Mr. Huff may be deemed to share beneficial ownership of the securities held of record by Freebird Partners.
Pursuant to that certain Securities Purchase Agreement dated January 2, 2023, the Company issued that certain Common Stock Purchase Warrant ("Warrant") to Freebird Partners LP, in substantially the form as the form of warrant filed as Exhibit 4.1 to the Issuer's Current Report on Form 8-K filed with the Securities and Exchange Commission (the "SEC") on January 4, 2023. The Warrant became exercisable on January 4, 2023, and may be exercised through January 4, 2028, at an exercise price of $1.23 per share of Common Stock.
Pursuant to that certain Securities Purchase Agreement dated July 31, 2023, the Company issued that certain Common Stock Purchase Warrant ("First Warrant") to Freebird Partners LP on July 31, 2023, in substantially the form as the form of warrant filed as Exhibit 4.1 to the as announced in the Issuer's Current Report on Form 8-K filed with the SEC on August 1, 2023. The First Warrant becomes exercisable on February 1, 2024, and may be exercised through July 31, 2028, at an exercise price of $0.6135 per share of Common Stock.
Pursuant to that certain Securities Purchase Agreement dated July 31, 2023, the Company issued that certain Common Stock Purchase Warrant ("Second Warrant") to Freebird Partners LP on September 11, 2023, in substantially the form as the form of warrant filed as Exhibit 4.1 to the as announced in the Issuer's Current Report on Form 8-K filed with the SEC on August 1, 2023. The Second Warrant became exercisable on September 11, 2023, and may be exercised through September 11, 2028, at an exercise price of $0.6135 per share of Common Stock.
Freebird Partners LP, By: Freebird Investments LLC, its general partner, By: /s/ Curtis W. Huff, Chairman and President
2024-01-03
Freebird Investments LLC, By: /s/ Curtis W. Huff, Chairman and President
2024-01-03
/s/ Curtis W. Huff
2024-01-03